Ru Chih C. Huang

Dr. Ru Chih C. Huang

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CCChih-Chuan Chang
Chih-Chuan Chang
JHJonathan D. Heller
Jonathan D. Heller
JKJennifer Kuo
Jennifer Kuo
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang
We previously reported that Sp1-dependent Cdc2 gene expression is inhibited by tetra- O -methyl nordihydroguaiaretic acid (M 4 N) and that M 4 N is likely responsible for causing growth arrest in M 4 N-treated transformed C3 cells. Here, we show that after M 4 N treatment and cell-cycle arrest, expression of the Sp1-dependent survivin gene, a member of the inhibitor of apoptosis family, is also suppressed, and the mitochondrial apoptotic pathway is activated. To confirm that inhibition of Cdc2 and survivin gene expression is necessary for M 4 N-induced growth arrest and apoptosis, we tested the effect of adding Cdc2 and survivin back to M 4 N-treated cells. Cell division was transiently restored in the presence of M 4 N after transfection of an exogenous Cdc2 gene copy under the control of the Sp1-independent cytomegalovirus promoter. Caspase-3 activation was also reduced by 50% and 75% in transiently and stably survivin-transfected C3 cells, respectively. The results suggest that M 4 N induces growth arrest and apoptosis by suppressing Cdc2 and survivin expression, which constitutes the cellular basis of its antitumoric action.

12 March 2015 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
JGJohn Gnabre
John Gnabre
RBRobert Bates
Robert Bates
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang
The medicinal properties of the most successful plant in the deserts of the western hemisphere, the creosote bush (Larrea tridentata), are evidenced by the long traditional usage of the plants by the Native Americans Indian tribes in Southwestern North America and the Amerindians from South America. The plant is rich in simple bisphenyl lignans and tricyclic lignans known as cyclolignans. These compounds are responsible for many of the pharmacological activities of extracts of the plants. Some of these activities, namely antiherpes, antioxidant, antifungal, and anti-inflammatory, were known a century ago. Only recently have further studies revealed other crucial activities of the same plant molecules as powerful agents against human immunodeficiency virus, human papillomavirus, cancer, neurodegenerative diseases, and symptoms of aging. Molecular mechanisms underlying the antiviral and anticancer activities have been elucidated and involve the inhibition of SP1 dependent gene transcription. This review summarizes the recent findings on creosote bush lignans. We introduce the concept of a cocktail of safe well-characterized natural products from the creosote bush that would represent a bridge between oriental herbal medicines and Western drug-based therapies.

17 March 2006 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
CCChih-Chuan Chang
Chih-Chuan Chang
YLYu-Chuan Liang
Yu-Chuan Liang
AKAthena Klutz
Athena Klutz
CHChuan-I Hsu
Chuan-I Hsu
CLChien-Fu Lin
Chien-Fu Lin
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang

Verified
Journal Article
Open access
PDF file
KKKotohiko Kimura
Kotohiko Kimura
TJTiffany L. B. Jackson
Tiffany L. B. Jackson
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang
Specificity protein 1 (SP1), hypoxia-inducible factor 1 (HIF-1), and MYC are important transcription factors (TFs). SP1, a constitutively expressed housekeeping gene, regulates diverse yet distinct biological activities; MYC is a master regulator of all key cellular activities including cell metabolism and proliferation; and HIF-1, whose protein level is rapidly increased when the local tissue oxygen concentration decreases, functions as a mediator of hypoxic signals. Systems analyses of the regulatory networks in cancer have shown that SP1, HIF-1, and MYC belong to a group of TFs that function as master regulators of cancer. Therefore, the contributions of these TFs are crucial to the development of cancer. SP1, HIF-1, and MYC are often overexpressed in tumors, which indicates the importance of their roles in the development of cancer. Thus, proper manipulation of SP1, HIF-1, and MYC by appropriate agents could have a strong negative impact on cancer development. Under these circumstances, these TFs have naturally become major targets for anticancer drug development. Accordingly, there are currently many SP1 or HIF-1 inhibitors available; however, designing efficient MYC inhibitors has been extremely difficult. Studies have shown that SP1, HIF-1, and MYC modulate the expression of each other and collaborate to regulate the expression of numerous genes. In this review, we provide an overview of the interactions and collaborations of SP1, HIF1A, and MYC in the regulation of various cancer-related genes, and their potential implications in the development of anticancer therapy.

17 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KKKotohiko Kimura
Kotohiko Kimura
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang
The ability of Tetra-O-methyl nordihydroguaiaretic acid (M4N) to induce rapid cell death in combination with Etoposide, Rapamycin, or UCN-01 was examined in LNCaP cells, both in cell culture and animal experiments. Mice treated with M4N drug combinations with either Etoposide or Rapamycin showed no evidence of tumor and had a 100% survival rate 100 days after tumor implantation. By comparison all other vehicles or single drug treated mice failed to survive longer than 30 days after implantation. This synergistic improvement of anticancer effect was also confirmed in more than 20 cancer cell lines. In LNCaP cells, M4N was found to reduce cellular ATP content, and suppress NDUFS1 expression while inducing hyperpolarization of mitochondrial membrane potential. M4N-treated cells lacked autophagy with reduced expression of BNIP3 and ATG5. To understand the mechanisms of this anticancer activity of M4N, the effect of this drug on three cancer cell lines (LNCaP, AsPC-1, and L428 cells) was further examined via transcriptome and metabolomics analyses. Metabolomic results showed that there were reductions of 26 metabolites essential for energy generation and/or production of cellular components in common with these three cell lines following 8 hours of M4N treatment. Deep RNA sequencing analysis demonstrated that there were sixteen genes whose expressions were found to be modulated following 6 hours of M4N treatment similarly in these three cell lines. Six out of these 16 genes were functionally related to the 26 metabolites described above. One of these up-regulated genes encodes for CHAC1, a key enzyme affecting the stress pathways through its degradation of glutathione. In fact M4N was found to suppress glutathione content and induce reactive oxygen species production. The data overall indicate that M4N has profound specific negative impacts on a wide range of cancer metabolisms supporting the use of M4N combination for cancer treatments.

19 February 2003 in Antiviral Research
Verified
Journal Article
Closed access
Ru Chih C. HuangRu Chih C. Huang
Ru Chih C. Huang
YLYen Li
Yen Li
PGPaul E. Giza
Paul E. Giza
JGJohn N. Gnabre
John N. Gnabre
IAIbrahim S. Abd-Elazem
Ibrahim S. Abd-Elazem
Jih Ru HwuJih Ru Hwu
Jih Ru Hwu